Department of Biophysics, Kyoto University Graduate School of Science, Kyoto 606-8502, Japan.
Cereb Cortex. 2014 Apr;24(4):1017-29. doi: 10.1093/cercor/bhs387. Epub 2012 Dec 12.
Development of the cerebral cortex depends partly on neural activity, but the identity of the ion channels that might contribute to the activity-dependent cortical development is unknown. KCNK channels are critical determinants of neuronal excitability in the mature cerebral cortex, and a member of the KCNK family, KCNK9, is responsible for a maternally transmitted mental retardation syndrome. Here, we have investigated the roles of KCNK family potassium channels in cortical development. Knockdown of KCNK2, 9, or 10 by RNAi using in utero electroporation impaired the migration of late-born cortical excitatory neurons destined to become Layer II/III neurons. The migration defect caused by KCNK9 knockdown was rescued by coexpression of RNAi-resistant functional KCNK9 mutant. Furthermore, expression of dominant-negative mutant KCNK9, responsible for the disease, and electrophysiological experiments demonstrated that ion channel function was involved in the migration defect. Calcium imaging revealed that KCNK9 knockdown or expression of dominant-negative mutant KCNK9 increased the fraction of neurons showing calcium transients and the frequency of spontaneous calcium transients. Mislocated neurons seen after KCNK9 knockdown stayed in the deep cortical layers, showing delayed morphological maturation. Taken together, our results suggest that dysfunction of KCNK9 causes a migration defect in the cortex via an activity-dependent mechanism.
大脑皮层的发育部分依赖于神经活动,但对于可能有助于活性依赖皮层发育的离子通道的身份尚不清楚。KCNK 通道是成熟大脑皮层神经元兴奋性的关键决定因素,KCNK 家族的一个成员 KCNK9,负责一种母系遗传性智力迟钝综合征。在这里,我们研究了 KCNK 家族钾通道在皮层发育中的作用。使用胚胎电穿孔的 RNAi 敲低 KCNK2、9 或 10 会损害晚期出生的皮质兴奋性神经元的迁移,这些神经元注定成为 II/III 层神经元。KCNK9 敲低引起的迁移缺陷可通过共表达 RNAi 抗性功能性 KCNK9 突变体得到挽救。此外,表达导致疾病的显性负突变 KCNK9 和电生理实验表明离子通道功能参与了迁移缺陷。钙成像显示 KCNK9 敲低或表达显性负突变 KCNK9 增加了显示钙瞬变的神经元的分数和自发钙瞬变的频率。KCNK9 敲低后出现的错位神经元仍留在皮质深层,表现出延迟的形态成熟。总之,我们的结果表明,KCNK9 的功能障碍通过活性依赖机制导致皮层迁移缺陷。